Pre-clinical evidence demonstrates PBT434 as a potential treatment for MSA October 5, 2018August 16, 2022
Alterity Therapeutics Receives U.S. FDA Approval for Investigational New Drug Application for ATH434 for the Treatment of Multiple System Atrophy September 20, 2022May 23, 2023